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Abstract 
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Background: Maternal infections during pregnancy increase the risk of fetal death; dengue is a 
common infection, but little is known about its role in fetal mortality. We conducted a nested 
case control study investigating the association between symptomatic dengue during pregnancy 
and fetal death.  
Methods: Using obstetrician-collected data from the Brazilian Information System of Births 
(SINASC), Information System of Mortality (SIM) and Notification of Infectious Diseases 
(SINAN), we identified all pregnancies ending in stillbirth and a random sample of live births 
between 2006 and 2012. We used linkage to establish which mothers were notified with dengue 
during pregnancy. Using stillbirths as cases and a sample of matched live births as controls, we 
calculated matched odds ratios (mORs) using conditional logistic regression, adjusting for 
maternal age and education.  
Findings: The mothers of 275/162,188(0.2%) stillbirths were notified with dengue during 
pregnancy, compared with 1507/1,586,105(0.1%) mothers of live births. Symptomatic dengue 
during pregnancy doubled the odds of fetal death (mOR1.9,95%CI1.6-2.2). The increase in risk 
was similar when restricting analyses to laboratory confirmed diagnosis of dengue 
(mOR1.8,95%CI1.4-2.4). Severe dengue increased the risk of fetal death fivefold (mOR 
4.9,95%CI 2.3-10.2). The proportion of all fetal deaths attributable to notified dengue during 
pregnancy was small(0.08%), but as expected, increased during epidemic years(0.13% in 
2010). 
Interpretation: We provide powerful evidence that symptomatic dengue during pregnancy 
increases the risk of fetal death; we recommend further research on the association between 
dengue and poor births outcomes. 
Funding: ESP is funded by the National Counsel of Technological and Scientific Development 
(CNPq), Brazil and LCR is partially funded by the European Union’s Horizon 2020 research 
and innovation program under Zika- PLAN grant agreement No. 734584.  
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Introduction  
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Fetal deaths are a common adverse outcome of pregnancy, even in developed countries. 
Although the global burden of stillbirths declined by 25.5% between 2000 and 2015, there were 
still 2.6 million stillbirths worldwide in 20151. Stillbirth rates vary from an estimated 4/1000 
births in high incomes countries to 26/1000 births in low-middle income countries1.  
Infections during pregnancy are believed to cause between 10%-25% of all fetal deaths in high 
income countries2, with infections in early pregnancy carrying a higher risk;3,4 infection in the 
first 28 weeks causing 15% of all fetal deaths, and infections later than 28 weeks causing 6%5. 
The contribution of viral infections is estimated to be 14.5%6, although it is possible that a 
proportion of unexplained stillbirths could be due to undiagnosed viral infections7.  
The recent confirmation of zika as a cause of congenital anomalies and stillbirth highlighted 
the importance of original research on the effect of flavivirus on stillbirths8.A review by Mc 
Clure and collegues9 (2014) mentioned dengue as a cause of fetal death, yet there are no 
population-based studies showing this association. In 2010, a systematic review concluded that 
whether dengue during pregnancy had any negative effect on fetal outcomes remained 
unclear10. A recent systematic review found that only one study of dengue infection during 
pregnancy and fetal death had a comparison group11. They included thirteen stillbirths (nine 
exposed to dengue) and the crude relative risk was 6·7 (95% CI 2.1-21.3) in women with 
symptomatic dengue compared with women without dengue12. All other evidence to date 
comes from case reports or case series, none of which include appropriate controlling for 
confounding or population control groups. The mechanisms of how dengue could lead to a 
stillbirth is unknown but there are three main hypotheses: 1) direct effect of mother´s illness  
(severe dengue); 2) the placenta might be affected by the changes caused by the disease; 3) the 
direct effect of virus on fetus2. Although the incidence of dengue is increasing dramatically and 
approximately half of the global population is at risk, including women of reproductive age13, 
the effects of dengue infection during pregnancy on fetal mortality remain unclear. Here, we 
report the analysis of a population-based nested case-control study, which, adjusting for 
confounding variables, investigates the association between stillbirth and symptomatic dengue 
during pregnancy 
 
Methods 
Study design  
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We conducted a population-based nested case-control study using linkage of routine data on 
all pregnant women whose outcomes were live birth and stillbirth in Brazil, from January 1, 
2006 to December 31, 2012.  
Data sources 
Data were extracted from three Brazilian databases: The Live Births Information System 
(Sistema de Informação sobre Nascimentos; SINASC), Mortality Information System (Sistema 
de Informação sobre Mortalidade; SIM), and Notifiable Diseases Information System (Sistema 
de Informação de Agravos de Notificação; SINAN). They contain respectively, records of all 
live births, all stillbirth and all notifiable diseases, in Brazil. SINASC consists of data from live 
birth notifications, a legal document completed by the health professional who assisted the 
delivery. It is the required document for a legal existence and includes information on the 
mother (name, place of residence, age, marital status, education, whether she had a stillbirth or 
a child who died); the pregnancy (length of gestation, type of delivery); and the newborn (birth 
weight, presence of congenital anomalies)14. The completeness of the data is very high, with 
most variables completed in over 90% of cases; the exception being information on whether 
the mother had a previous stillbirth or abortion15. Data in SIM come from the Death Certificate, 
a legal document16. The proportion of records with missing data varies by variable, and is 
around 20% on maternal education and number of previous fetal deaths or abortions. Data on 
notifiable diseases, including personal information on the patient (name, place of residence, 
age, education), symptoms of disease, laboratory tests, and disease severity are captured in the 
third system, SINAN, which contains reasonably complete data on the variables we used for 
linkage and in the final analyses (<0.05% records were excluded because of missing name). 
SINAN contains two sources of information on maternal age (age and date of birth). 
Approximately 5% of dengue cases did not have a final classification of severity. Laboratory 
confirmation was not required for notification of dengue cases because dengue was the main 
(and for some years the only)  vector borne disease circulating in Brazil (yellow fever and 
malaria occur in restricted areas; notification of Zika and Chikungunya were not introduced 
until 2014).  
 
Linkage process  
SINAN–Dengue records were linked probabilistically with the cohort of pregnant women from 
SINASC and SIM, in order to identify those who had dengue during pregnancy. Name, age 
and place of residence of the mother at time of delivery/notification were used in the matching 
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process. We excluded records with missing or implausible names and duplicates. Match weight 
calculations were based on the Fellegi-Sunter method17.  
A gold-standard dataset was created using all stillbirth records for two years of data (2009-
2010) and all live birth records within two states (Ceará and Espirito Santo) for one year  (2010) 
of data. Manual review of record pairs was performed to establish true matches (records 
belonging to the same mother) and estimate m-probabilities P(agreement|match); the 
probability of match given agreement on each identifier. To calculate the u-probabilities 
P(agreement|non-match), we used a subset of SINAN to create a set of non-matches, by cross 
joining all record pairs and removing record pairs belonging to the same individual. Records 
pairs were then ordered by match weight and manually inspected to identify obvious non-links 
that had high weights and probable links with low weights. Only links and non-links with a 
high degree of certainty were retained for the case-control study to avoid misclassification; 
uncertain links (where we could not establish whether or not a woman had dengue) were 
excluded from analyses.  
To evaluate the quality of the linkage algorithm, we compared the links obtained using the 
probabilistic algorithm with the gold-standard created by manual review. This validation 
demonstrated that for stillbirths and live births, sensitivity was 64.% and 62% respectively; the 
positive predictive value was 94% for stillbirths and 95% for live births; specificity was >99% 
for both. The missed matches occurred randomly in cases and controls (appendix). The 
procedures and evaluation of the matching process are the subject of a separate paper.  
 
Procedures 
In SIM, stillbirth was defined as the death  of a product of conception before the expulsion or 
complete extraction from the body of the pregnant woman, occurring from 22 weeks or 
weighing more than 500g, according to Brazilian definition16.  
In SINASC, live birth was defined as the product of conception that independent of the duration 
of pregnancy, after the separation from the mother's body, breathes or shows any other signs 
of life, such as heartbeat, umbilical cord pulsation, or definite movement of voluntary muscles 
according to Brazilian definition14.  
Records with missing or implausible name of the mother, multiple pregnancy, congenital 
anomalies, birth and stillbirth from municipalities without dengue notification and uncertain 
links status were excluded in cases and controls (Figure 1). Multiple pregnancy and congenital 
anomalies were excluded because they might be on the causal pathway for stillbirth. 
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We include stillbirths recorded in SIM as cases, and as controls, we used a random sample of 
10 live births (without replacement), matched to cases by month and calendar year, born to a 
woman living in the municipality of residence of the mother of the case. To select the matched 
control we matched cases and controls only if they have the same month/ year and place of 
birth. We randomly ordered cases and controls within month/ year and place of birth groups, 
and selected the first case in the group to be matched to the first 10 controls in the group. The 
second case was matched to controls 11 to 20, and so on, forming pairwise combinations. We 
selected 10 controls per case to allow control for potential confounders such as dengue 
seasonality, intensity of the virus circulation and social environment.  
The exposure in this case control study was being a notified confirmed cases of dengue during 
pregnancy that resulted in the birth of the case or the control. Dengue in Brazil can be confirmed 
based on clinical / epidemiological criteria- presence of clinical symptoms of dengue in an area 
and time as other confirmed cases of dengue, or clinical/ laboratory criteria- presence of clinical 
symptoms and laboratory confirmation (positive test from one of IgM detection by ELISA, 
viral RNA detection via PCR, NS1 viral antigen detection, or positive viral culture). In this 
report, a subject was considered to be “exposed” if their mother was notified to SINAN and 
confirmed as dengue case (and therefore their records were linked to a notification of dengue 
during the pregnancy). “Dengue during pregnancy” refers to all confirmed cases of dengue 
(clinical/epidemiological and clinical/laboratorial); “dengue during pregnancy laboratorial 
confirmed” refers to only the laboratorial confirmed cases. We classified dengue in two clinical 
categories: dengue fever as a self-limiting disease (fever, with severe headache, pain behind 
the eyes, muscle and joint pain, and rash) or severe dengue. We classified as severe dengue, all 
cases of dengue that the Brazilian Ministry of Health classified as dengue haemorrhagic fever 
(DHF), dengue shock syndrome (DSS) and complicated dengue. Complicated dengue is a 
Brazilian definition of all severe cases of dengue that did not meet the WHO criteria for DHF 
(fever, haemorrhagic evidence, thrombocytopenia and evidence of plasma leakage) and could 
not be classified as mild self-limited disease due to its severity. Complicated dengue is used 
when a probable case of dengue presented one of the following manifestations: severe changes 
in the nervous system, cardiorespiratory dysfunction; insufficient hepatic function; 
gastrointestinal bleeding, cavity spills, thrombocytopenia equal or less than 50,000/mm3 , 
leucometry less than 1000/mm3 18. We used only two clinical categories because of the small 
numbers of observations, since the severe form of dengue is a rare outcome.  
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Ethical approval was obtained from Federal University of Bahia, Salvador, Brazil (CAAE: 
26797814.7.0000.5030) and from London School of Hygiene and Tropical Medicine (Ethics 
Ref:10269).  
 
Statistical analysis 
To calculate the sample size, we conducted two preliminary deterministic linkages of records 
with 100% agreement in the three identifiers (name, age and municipality of the mother); the 
first, between SINAN and SIM to calculate the minimum percentage of mothers of stillbirths 
who had dengue during pregnancy (0.05%) and between SINAN and SINASC to calculate the 
minimum percentage of mothers of live births who had dengue during pregnancy (0.03%). We 
estimated that with 94,755 cases, we would be able to detect a matched odds ratio (mOR) of 
1.6, using the following parameters: proportion exposed as above, 80% power, 95% confidence 
level; ratio of ten controls: case(appendix).  
For the overall association, we estimated crude mORs from univariate conditional logistic 
regression and adjusted mORs using conditional logistic regression, controlling for maternal 
age and maternal education (as a proxy of socioeconomic status). For a sensitivity analysis of 
the validity of dengue clinical diagnosis, we repeated analysis with laboratory confirmed 
dengue only. We investigated the effect of dengue by disease severity and time between the 
disease and outcome. An analysis stratified by report of a previous fetal death or abortion 
explored whether dengue had a different effect in pregnancies at high risk of fetal death. To 
investigate the potential impact of missing data, we conducted another sensitivity analysis in 
which we assumed that all missing data in confounding variables in the cases were in the low 
risk groups and all the missing data in the controls were in the high risk groups.  
 
The population attributable fraction (PAF= [p1(OR-1)] / OR) was calculated using the punafcc 
package available in STATA software, that uses a logistic regression method 19, which provides 
PAF (and 95% CI) adjusted for confounding variables by combining adjusted ORs and the 
observed incidence of dengue among cases (stillbirths). We used Stata version 14.1 software 
for the statistical analyses. 
 
Role of the funding source 
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The funder of this study had no role in study design, data collection, data analysis, 
interpretation, or writing of the report. All authors had full access to all de-identified data in 
the study and had final responsibility for the decision to submit for publication. 
Results  
The Brazilian Information System recorded 224,582 stillbirths and 20,333,482 livebirths 
during the study period. After exclusions, 162,781 stillbirths were eligible for the study. No 
control was matched for 583 (0.3%) stillbirths and these were excluded. The final study 
population included 162,188 stillbirths and 1,586,105 livebirths, with 275 stillbirths and 1,507 
live births exposed (Figure 1). 
The characteristics of cases and controls are shown in Table 1. The proportion of missing values 
for all variables was higher among cases than in controls, including classical risk factors for 
stillbirth, such as previous fetal death or abortion (28.3%) and maternal education (27.5%). This 
was also true for age, birth or death weight, and gestational age.  
The risk of stillbirth among all births recorded in the information system was 11/1000 live 
births. The risk of a stillbirth in women who had dengue during pregnancy was 15/1000 
pregnancies (95% CI 13-17/1000). Overall, dengue was laboratory confirmed in more than 
30% of the dengue cases recorded. Dengue during pregnancy was more common in mothers of 
cases(0.2%) than in mothers of controls(0.1%). Potential confounder variables (i.e. variables 
associated with dengue and with stillbirth) were maternal education and previous fetal death or 
abortion(Table 2). 
The crude association between symptomatic dengue during pregnancy and stillbirth was mOR 
1.8 (95%CI 1.6-2.0), and was similar when adjusting for maternal education and maternal age 
(mOR 1.9, 95% CI 1.6-2.2). Analysis restricted to laboratory confirmed dengue only gave a 
similar adjusted mOR (1.8, 95% CI 1.4-2.4). We investigated if the association between dengue 
and stillbirth depended upon previous fetal death or abortion, but the odds ratio did not differ 
according to this variable category (with mOR:1.6, without mOR:1.8). The  risk of fetal death 
is dependent on time between first symptoms of dengue and the date of live/stillbirth: it appears 
to be bimodal. It  peaked  in the first twenty days after the onset of dengue at mOR 4.9, 95% 
CI 2.9-6.3, (more marked when dengue is severe ).  After 10 days, the  risk of mortality remains 
raised, (mOR1.7 ; 95% CI 1.4-2.0).but at a roughly constant rate, until the end of pregnancy 
(Figure 2). Severe dengue during pregnancy increased the risk of stillbirth fivefold (mOR 4.9, 
95% CI 2.3-10.2), almost 3 times that of mild dengue (mOR 1.7, 95% CI 1.5-2.0) (Table 3).  
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A sensitivity analysis was conducted because the proportion of missing data was higher among 
cases than controls. We assumed that all missing data in confounding variables in the cases 
were in the low risk groups and all the missing data in the controls were in the high risk groups. 
The magnitude of the association was very similar (mOR 1.8, 95% CI 1.5- 2.0). 
The prevalence of symptomatic dengue during pregnancy was low (0.1% of mother of controls 
were notified with dengue during pregnancy), so the PAF was also low: 0.08% of all stillbirths 
during the period were attributable to dengue, with marked yearly variation and a maximum of 
0.13% during epidemic years(appendix).  
 
Discussion  
 
Symptomatic dengue during pregnancy roughly doubled the risk of stillbirth, with the highest 
risk observed in the first twenty days after disease onset and in women with severe disease. 
The increase in risk was the same for all cases of dengue (either clinical epidemiological or 
laboratory diagnosis) as with laboratory confirmed dengue only. Dengue during pregnancy is 
relatively rare, and the proportion of all fetal deaths attributable to dengue during pregnancy in 
Brazil during the period was relatively small, but larger during epidemic years.  
This is the first study to evaluate the risk of stillbirth among women with dengue during 
pregnancy using a population-based approach, with a sufficiently large sample size and 
controlling for confounders, although we were not able to adjust for all possible confounding 
factors as we were relying on routine information that is obtainable from notification system 
records. Results are consistent with a study conducted in the French Guiana, where the risk of 
stillbirth was higher among pregnancies with symptomatic dengue, although their estimate of 
risk was higher12. Stillbirth has been associated with other viral maternal infections and the 
magnitude of this association varies given the organisms, severity of maternal illness, 
gestational age and others factors. For example, maternal influenza that required hospitalization 
increased the risk of fetal death in 4.2 (95% CI 1.4-12.4)20, whereas the risk of stillbirth on 
pregnant women with a mild disease was 1.9 (95% CI 1.1-3.4)21. The risk of stillbirth among 
women with HIV infection was 1.67 (95% CI 1.0-2.6)22.  
Although many viral infections increase the risk of fetal death, the mechanism for the 
association is not clear. The analysis of the length of time between symptoms of dengue and 
stillbirth and disease severity showed that the highest risk occurred during the acute maternal 
illness and in women with severe disease, suggesting that the mechanisms involved in the 
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association between dengue and stillbirth might be through maternal infection; if the mother 
becomes severely ill the fetus could die in the days following first symptoms, due to high fever 
or other systemic manifestations2. After this first period, in a small proportion of cases, other 
mechanisms could be relevant.  The proposed mechanism for the effect of some viral infections 
on pregnancy outcomes include direct fetus infection damaging vital organ such as brain and 
heart. However for dengue, vertical transmission has not been described as a common 
occurrence, although  virus and antibodies have been found in placentas, in cord blood of such 
infants and in the cells of lung and kidney of an aborted fetus23,24,25,26,27,28 . In the absence of 
vertical transmission, harm to the fetus might result from the alterations that remain after the 
infection is over. This would include pathological changes in placenta leading to hypoxia as 
proposed by Ribeiro et al (2007)29. However we cannot elucidate this mechanism in this study, 
this could be clarified by further research with detailed  clinical information (including 
information on medication and co-morbidities), and full investigation using appropriate 
instruments and specific laboratory techniques. These studies could be conducted in much 
smaller number of patients. 
According to a systematic review of small previous studies11, and a comment by Carles30 
(2016), and another study using similar Brazilian data31, dengue is associated with adverse fetal 
outcomes and severe forms of the disease carry a higher risk. This was ratified in our study, 
where the risk of stillbirth among women that developed the severe forms of dengue was almost 
three times that of those with mild disease. Because history or fetal loss is a risk factor for new 
stillbirths5, we investigated if this variable acted as an effect modifier, but found that the 
association was similar for women with and without a previous stillbirth. 
 
Our study has limitations and strengths inherent to the linkage process and to utilization of 
secondary data. In relation to the use of secondary data, we showed very good agreement on 
the estimates of risk in cases with and without laboratory confirmation. Our data set us some 
challenges for linkage, and the process and validation of the linkage will be discussed in a 
separate paper. However, it is unlikely that the linkage process introduced bias, because linkage 
errors occurred randomly across cases and controls. Missing data were more frequent in cases 
than controls. A consequence of this could be better linkage among controls, which would 
decrease the magnitude of the observed association. However, the validation study showed a 
linkage sensitivity of near 60% for both cases and controls, so the magnitude of the association 
should not be affected by linkage error, although the PAF will be underestimated.  
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Strengths of our study are the very large sample size, including all confirmed cases notified in 
a country where dengue incidence is high and variable over time. We also had a rigorously 
selected group of controls and were able to control for confounding. The sensitivity analyses 
demonstrate the robustness of our findings. 
Despite these limitations, we provide strong evidence that symptomatic dengue during 
pregnancy is a risk factor for stillbirth, with higher risk in severe forms during the acute phase. 
We recommend further research in different settings to confirm our results, and explore further 
other negative outcomes of pregnancy (preterm birth, Intrauterine growth restriction (IUGR), 
congenital anomalies and maternal mortality) and studies of other vector-borne diseases 
contributing to fetal death. Additional research is required to measure the burden of sub clinical 
maternal viral infections in stillbirths and elucidate the pathological mechanisms involved in 
this relationship. If the association between dengue and stillbirth were demonstrated in others 
studies, recommendations should be made for close monitoring of pregnant women with 
dengue symptoms, for incorporating dengue control on programmes to reduce fetal mortality, 
and for including pregnant women as an at-risk population in dengue control programmes, in 
order to strengthen the health education actions for individual protection of pregnant women. 
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